Dr. Steven R Hill, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 30729 Lyon Center Dr E, New Hudson, MI 48165 Phone: 248-486-3491 |
Pearle Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 30434 Milford Rd, New Hudson, MI 48165 Phone: 248-587-5100 Fax: 248-587-5103 |
News Archive
A new study describing the outcome of a clinical trial of two malaria treatment protocols involving the use of triple therapies based on artemisinin reports their high efficacy and low adverse effects.
Astronomers at the University of California, Riverside, have teamed with teachers at the California School for the Deaf, Riverside, or CSDR, to design an astronomy workshop for students with hearing loss that can be easily used in classrooms, museums, fairs, and other public events.
Inhibitex, Inc. today reported top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily doses of FV-100 (200 mg and 400 mg) to an active control, valacyclovir, one of the most commonly-used antiviral drugs to treat shingles.
Women 55 and older have an increased risk of bone and muscle loss but therapy with the hormone Dehydroepiandrosterone may help prevent bone loss and increase muscle mass in older women, according to a new study led by Catherine M. Jankowski, PhD, FACSM, an exercise physiologist and associate professor at the University of Colorado College of Nursing at the Anschutz Medical Campus.
› Verified 6 days ago